City

Detroit (1)

Houston (1)

Los Angeles (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Jonsson Comprehensive Cancer Center (1)

M.D. Anderson Cancer Center (1)

Collaborator

Merck Sharp & Dohme LLC (1)

National Cancer Institute (NCI) (1)

Intervention

carboplatin (2)

cabazitaxel (1)

cisplatin (1)

docetaxel (1)

etoposide (1)

laboratory biomarker analysis (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

prostate small cell carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting

Bladder Small Cell Neuroendocrine Carcinoma
+16 more

Carboplatin
+4 more

Los Angeles, California

UCLA / Jonsson Comprehensive Cancer Center

Mar 23, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Lymphadenopathy Trial in Detroit, Houston

Completed

Has Results

Castration Levels of Testosterone
+6 more

Cabazitaxel
+2 more

Detroit, Michigan
+1 more

Jul 29, 2021